SARS-CoV-2
Showing NaN - NaN of 14
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
Recruiting
- SARS-CoV-2
- SPIKEVAX
-
New York, New YorkAetion, Inc
Nov 8, 2023
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273.211
- +6 more
-
Sacramento, California
- +22 more
Nov 16, 2022
SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273
-
Mesa, Arizona
- +14 more
Aug 31, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
COVID-19 Vaccination and Breakthrough Infections Among Persons
Completed
- Immunocompromised
- +5 more
- BNT162b2 (Tozinameran)
-
New York, New YorkPfizer Inc.
Jul 1, 2022
SARS-CoV-2 Trial in New York (Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose)
Recruiting
- SARS-CoV-2
- Sodium Chloride
- +4 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 30, 2022
Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among
Completed
- SARS-CoV-2
-
New York, New YorkAetion Inc.
May 5, 2022
COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,
Completed
- COVID-19
- +3 more
- Hydroxychloroquine Sulfate
- Ascorbic Acid
-
Los Angeles, California
- +7 more
Dec 14, 2021
SARS-CoV-2-specific Immunity in Individuals Who Have Recovered
Active, not recruiting
- SARS-CoV-2
- COVID-19
- Sample collection
-
Birmingham, Alabama
- +52 more
Sep 3, 2021
The Covid-19 HEalth caRe wOrkErS (HEROES) Study
Recruiting
- Covid-19
- +5 more
- Exposure to the SARS-CoV-2 and its consequences
-
New York, New York
- +21 more
Mar 26, 2021
COVID-19: Human Epidemiology and Response to SARS-CoV-2
Completed
- Coronavirus Disease 2019 (COVID-19)
- SARS-CoV-2
- Collection of Biological Samples
- Symptom and Exposure Surveys
-
Aurora, Colorado
- +19 more
Feb 11, 2021
COVID-19, COVID19, Sars-CoV2 Trial in New York (Hydroxychloroquine, Placebo)
Withdrawn
- COVID-19
- +3 more
- Hydroxychloroquine
- Placebo
-
New York, New YorkMemorial Sloan - Kettering Cancer Center
Oct 29, 2020